The Organisation for Economic Cooperation and Development (OECD) has warned enforcers that structural remedies may not be sufficient to remedy anticompetitive deals during the COVID-19 pandemic and urged authorities to be “extremely quick” when dealing with collaboration guidance requests.
Last week, the OECD issued guidance to help governments and antitrust authorities navigate issues around merger control, competitor collaboration and exploitative pricing in the wake of the coronavirus pandemic.
Merger control
Without a thorough merger review, there is a serious risk that the coronavirus pandemic could lead to higher market concentration and market power in several sectors, causing price increases, harm to innovation and productivity, the OECD’s competition division stated in its guidance on merger control last Monday, June 1.
The OECD warned that during unparalleled economic uncertainty, competition authorities will face key challenges in exercising merger control powers and increased pressure to speed up merger reviews. These challenges include increased uncertainty about how markets will evolve and an influx of failing firm defence claims as companies try to acquire competitors in financial difficulty, reported Global Competition Review.
Full Content: OECD, OECD, OECD
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Judge Mehta Questions Both Sides in Landmark Google Antitrust Case
May 2, 2024 by
CPI
FCC Urges Urgent Funding for Removal of Chinese Telecom Equipment from U.S. Networks
May 2, 2024 by
CPI
Former Pioneer CEO Facing Potential Criminal Charges For Colluding With OPEC
May 2, 2024 by
CPI
South Korea’s Antitrust Regulator Greenlights K-Pop Powerhouse Deal
May 2, 2024 by
CPI
Exxon’s Pioneer Purchase Approved, Former CEO Barred from Board
May 2, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI